At Vetoquinol, we are convinced of the importance of scientific partnerships, or those with other stakeholders in animal health, to encourage innovation, creativity and effectiveness.
Acting together for global animal health
To ensure animal and human welfare and health throughout the world, we believe it is essential that the stakeholders in the animal health sector jointly commit to a global approach.
With this approach in mind, Vetoquinol is a member of IFAH Europe - the International Federation for Animal Health Europe. This federation represents the manufacturers of veterinary drugs, vaccines and other animal health products in Europe. It represents both corporate members and national associations for animal health in Europe. IFAH Europe is working to highlight animal health and its implications for human health in particular, and to promote a harmonised, innovative animal health market to ensure quality veterinary drugs.
Vetoquinol is also a member of the SIMV, the French association for animal medicines and reagents.
Research programmes, research grants and partnerships: furthering research
Vetoquinol fosters scientific partnerships with research teams (private and public institutes) and universities throughout the world. These partnerships are necessary both to stimulate innovation and to expand and deepen scientific knowledge, and thus make advancements in the field of animal health. For example:
* Université de Montréal
In Canada, Vetoquinol is a partner of the Université de Montréal and awards the Research Excellence Prize, which is given to a member of the teaching staff to recognise his or her work in the education of graduate students in veterinary science.
* The Cimalgex Research Grant Program
In 2014, Vetoquinol set up a research grant to provide funding for research projects that focus on the treatment of pain. Specialist veterinarians, who work in universities or in private clinics, are constantly looking to further knowledge and advance veterinary medicine. In order to do this, comparative studies are needed, and these are often complex and expensive. So to support this research, Vetoquinol became a sponsor and has made €50,000 available to this grant which will be used to further research into pain.
* Yellow Pearl research project
Yellow Pearl is a three-year collaborative research project between Vetoquinol and public research teams from veterinary schools and the INRA, the French National Institute for Agricultural Research. The project addresses the core issue of antibiotic use and the effects of antibiotic use on public health: as part of the effort to reduce antibiotic use, is it possible to establish treatment protocols that limit the adverse effects of antibiotic therapies while retaining their effectiveness? Several research teams were involved in the project. The outcomes of this research will be used to improve scientific knowledge about the use of marbofloxacin in the treatment of bovine respiratory infections.